Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P David Rogers

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiaeKatherine S Barker, Margaret M Pearson, P David Rogers
The Annals of Pharmacotherapy|December 31, 2009
Fluconazole prophylaxis in high-risk neonatesBrent N Reed, Kelly E Caudle, P David Rogers
The Journal of Antimicrobial Chemotherapy|December 19, 2018
Emerging threat of triazole-resistant Aspergillus fumigatusJeffrey M Rybak, Jarrod R Fortwendel, P David Rogers
Current Opinion in Microbiology|October 15, 2022
The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida aurisJeffrey M Rybak, Christina A Cuomo, P David Rogers
Methods in Molecular Medicine|May 13, 2005
Application of proteomic analysis to the study of azole antifungal resistance in Candida albicansMassoumeh Z Hooshdaran, George M Hilliard, P David Rogers
Pharmacotherapy|May 14, 2003
Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulationsJohn D Cleary, P David Rogers, Stanley W Chapman
Molecular Microbiology|June 26, 2008
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strainsNico Dunkel, Julia Blass, P David Rogers, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|March 22, 2016
A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein AntigensCalvin C Daniels, P David Rogers, Chasity M Shelton
Eukaryotic Cell|June 21, 2011
Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1Sabrina Schubert, Christina Popp, P David Rogers, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
Heat-induced superaggregation of amphotericin B attenuates its ability to induce cytokine and chemokine production in the human monocytic cell line THP-1P David Rogers, Katherine S Barker, Vanessa Herring, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|April 17, 2003
Identification of genes differentially expressed in association with reduced azole susceptibility in Saccharomyces cerevisiaeKatherine S Barker, Margaret M Pearson, P David Rogers
The Annals of Pharmacotherapy|December 31, 2009
Fluconazole prophylaxis in high-risk neonatesBrent N Reed, Kelly E Caudle, P David Rogers
The Journal of Antimicrobial Chemotherapy|December 19, 2018
Emerging threat of triazole-resistant Aspergillus fumigatusJeffrey M Rybak, Jarrod R Fortwendel, P David Rogers
Current Opinion in Microbiology|October 15, 2022
The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida aurisJeffrey M Rybak, Christina A Cuomo, P David Rogers
Methods in Molecular Medicine|May 13, 2005
Application of proteomic analysis to the study of azole antifungal resistance in Candida albicansMassoumeh Z Hooshdaran, George M Hilliard, P David Rogers
Pharmacotherapy|May 14, 2003
Variability in polyene content and cellular toxicity among deoxycholate amphotericin B formulationsJohn D Cleary, P David Rogers, Stanley W Chapman
Molecular Microbiology|June 26, 2008
Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strainsNico Dunkel, Julia Blass, P David Rogers, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|March 22, 2016
A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein AntigensCalvin C Daniels, P David Rogers, Chasity M Shelton
Eukaryotic Cell|June 21, 2011
Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1Sabrina Schubert, Christina Popp, P David Rogers, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2003
Heat-induced superaggregation of amphotericin B attenuates its ability to induce cytokine and chemokine production in the human monocytic cell line THP-1P David Rogers, Katherine S Barker, Vanessa Herring, et al.
Pageof 11